Y-mAbs Therapeutics, Inc. (YMAB) Cash Flow Quarterly - Discounting Cash Flows
YMAB
Y-mAbs Therapeutics, Inc.
YMAB (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
Report Filing: 2025-08-08 2025-08-08 2025-05-13 2025-03-04 2024-11-08 2024-08-12 2024-05-07
1234
Net Income/Starting Line -22.22 -3.24 -5.2 -6.79 -7 -9.25 -6.63
1234
Cash From Operating Activities -17.8 1.65 -6.91 -1.87 -10.66 0.298 -3.48
1234
Depreciation and Amortization 0.347 0.053 0.071 0.102 0.121 0.153 0.159
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 13.52 2.9 3.34 3.08 4.2 3.44 3.85
1234
Other Non-Cash Items -3.39 -1.94 -0.812 2.96 -3.6 0.232 0.492
1234
Changes in Working Capital -6.04 3.88 -4.32 -1.22 -4.38 5.72 -1.34
1234
Accounts Receivable 21.96 2 1.95 -0.292 18.3 -17.63 1.87
1234
Inventory -7.68 -2.42 -0.724 -3.48 -1.06 -0.05 -3.38
1234
Accounts Payable -1.14 4.88 -1.22 -3.66 -1.13 3.23 0.176
1234
Deferred Revenue -19.18 -0.58 -4.32 6.21 -20.49 20.17 -0.004
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities -0.127 0 -0.127 0 0 0 0
1234
Investments in Property Plant and Equipment -0.127 0 -0.127 0 0 0 0
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities 0 0 0 0 0 0 0
1234
Sales and Maturities of Investments 0 0 0 0 0 0 0
1234
Other Investing Activities 0 0 0 0 0 0 0
1234
Cash From Financing Activities 2.41 0.332 0.114 0.986 0.979 1.76 0.588
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 2.41 0.332 0.114 0.986 0.979 1.76 0.588
1234
Common Stock Repurchased 0 0 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 0 0 0 0 0 0 0
1234
Effect of Forex Changes on Cash -0.002 0 0 -0.004 0.002 0.001 0.001
1234
Net Change in Cash -5.83 1.98 -6.92 -0.888 -9.68 2.06 -2.89
1234
Cash at Beginning of Period 68.12 60.31 67.23 68.12 77.81 75.75 78.64
1234
Cash at End of Period 62.29 62.29 60.31 67.23 68.12 77.81 75.75
1234
Free Cash Flow -17.92 1.65 -7.04 -1.87 -10.66 0.298 -3.48
1234
Operating Cash Flow -17.8 1.65 -6.91 -1.87 -10.66 0.298 -3.48
1234
Capital Expenditure -0.127 0 -0.127 0 0 0 0
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program